Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S.
While radiation therapy as a discipline is well into maturity, new technology advances continue to drive the field forward. The following is a roundup of some of the most significant products to launch or be introduced in the last 12 months.
Image-guided Radiation Therapy Systems
If you enjoy this content, please share it with a colleague
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at The Ottawa Hospital (TOH, Ottawa, Ontario) by surprise. The medical center began acquiring the extra needed cancer treatment resources in 2009, when the hospital entered a partnership agreement with Elekta to reinforce its radiotherapy capacity with additional linear accelerators and software.
A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months earlier than radiologic imaging by detecting traces of tumor DNA in the blood after surgery. The test also identified patients most likely to relapse, both before and after chemotherapy.1 Results were published in the May issue of JAMA Oncology.
Philips and Alverno Laboratories, a provider of high-quality diagnostic testing services, announced that Alverno will fully implement digital pathology in its clinical laboratories. The laboratory network will use Philips IntelliSite Pathology Solution to assess and diagnose all clinical histology cases digitally, instead of using a microscope, with the aim of improving laboratory efficiency, quality and patient safety.
The Clario SmartWorklist intelligently manages picture archiving and communication system (PACS) reading workflow by automatically organizing each radiologist’s daily reading tasks according to their credentials, subspecialty, workload, availability, and more.
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more precise and personalized. This work will be a critical component of a new interdisciplinary research project funded with $1.4 million from the National Institutes of Health (NIH) that seeks to improve radiation therapy for high-risk prostate cancer patients.
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip arthroplasty implants pose minimal risk of thermal injury, according to a recent study. The findings were presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting, May 5-10 in Honolulu.
